{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:21:01Z","timestamp":1770448861178,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2017,2,15]]},"DOI":"10.5664\/jcsm.6452","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T15:58:23Z","timestamp":1487087903000},"page":"223-234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Spontaneous Adverse Event Reports Associated with Zolpidem in the United States 2003\u20132012"],"prefix":"10.1007","volume":"13","author":[{"given":"Carmen K.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald R.","family":"Grunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel S.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romano A.","family":"Fois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane R.","family":"Hanrahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandana","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"issue":"4","key":"1302013_CR1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3961\/jpmph.2012.45.4.219","volume":"45","author":"DY Kang","year":"2012","unstructured":"Kang DY, Park S, Rhee CW et al. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health. 2012;45(4):219\u2013226.","journal-title":"J Prev Med Public Health"},{"key":"1302013_CR2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.18773\/austprescr.2008.084","volume":"31","author":"LG Olson","year":"2008","unstructured":"Olson LG. Hypnotic hazards: adverse effects of zolpidem and other z-drugs. Aust Prescr. 2008;31:146\u2013149.","journal-title":"Aust Prescr"},{"key":"1302013_CR3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00228-013-1557-x","volume":"69","author":"C Victorri-Vigneau","year":"2013","unstructured":"Victorri-Vigneau C, Feuillet F, Wainstein L et al. Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol. 2013;69:1965\u20131972.","journal-title":"Eur J Clin Pharmacol"},{"key":"1302013_CR4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2869.2011.00919.x","volume":"20","author":"M Ben-Hamou","year":"2011","unstructured":"Ben-Hamou M, Marshall NS, Grunstein RR, Saini B, Fois RA. Spontaneous adverse event reports associated with zolpidem in Australia 2001\u20132008. J Sleep Res. 2011;20:559\u2013568.","journal-title":"J Sleep Res"},{"key":"1302013_CR5","volume-title":"Ambien-amnesia link no surprise to doctors","author":"LM Collins","year":"2015","unstructured":"Collins LM. Ambien-amnesia link no surprise to doctors. Desert News Utah Web site Accessed March 31, 2015 http:\/\/www.deseretnews.com\/article\/635192102\/Ambien-amnesia-link-no-surprise-to-doctors.html. Published March 16, 2006."},{"key":"1302013_CR6","volume-title":"Ambien Linked to \u201cSleep Eating\u201d","author":"DJ DeNoon","year":"2015","unstructured":"DeNoon DJ. Ambien Linked to \u201cSleep Eating.\u201d. WebMD Web site Accessed March 27, 2015 http:\/\/www.webmd.com\/sleep-disorders\/news\/20060315\/ambien-linked-to-sleep-eating. Published March 15, 2006."},{"key":"1302013_CR7","unstructured":"ABC News American Broadcasting Company News Web site. \u2018Sleepdriving\u2019 Wreaking Havoc on Roads. Accessed March 27, 2015 http:\/\/abcnews.go.com\/GMA\/Health\/story?id=1704089. Published March 9, 2006."},{"key":"1302013_CR8","first-page":"A393","volume":"32","author":"NS Marshall","year":"2009","unstructured":"Marshall NS, Glozier N, Grunstein RR. Thirty-fold spike in adverse event reporting associated with zolpidem use in australia was most likely caused by the media. Sleep. 2009;32(Abstract Suppl):A393.","journal-title":"Sleep"},{"key":"1302013_CR9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/1471-2458-13-489","volume":"13","author":"J Robertson","year":"2013","unstructured":"Robertson J, Walkom EJ, Bevan MD, Newby DA. Medicines and the media: news reports of medicines recommended for government reimbursement in Australia. BMC Public Health. 2013;13:489.","journal-title":"BMC Public Health"},{"issue":"4","key":"1302013_CR10","doi-asserted-by":"crossref","first-page":"e001607","DOI":"10.1136\/bmjopen-2012-001607","volume":"2","author":"K Faasse","year":"2012","unstructured":"Faasse K, Gamble G, Cundy T, Petrie KJ. Impact of television coverage on the number and type of symptoms reported during a health scare: a retrospective pre-post observational study. BMJ Open. 2012;2(4):e001607.","journal-title":"BMJ Open"},{"issue":"10","key":"1302013_CR11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2165\/00002018-200730100-00007","volume":"30","author":"A Pariente","year":"2007","unstructured":"Pariente A, Gregoire F, Fourrier-Reglat A, Haramburu F, Moore N. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf. 2007;30(10):891\u2013898.","journal-title":"Drug Saf"},{"issue":"4","key":"1302013_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40264-014-0150-2","volume":"37","author":"KB Hoffman","year":"2014","unstructured":"Hoffman KB, Dimbil M, Erdman CB, Tatonetti NP, Overstreet BM. The Weber effect and the United States Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010. Drug Saf. 2014;37(4):283\u2013294.","journal-title":"Drug Saf"},{"issue":"6","key":"1302013_CR13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1592\/phco.24.8.743.36068","volume":"24","author":"NR Hartnell","year":"2004","unstructured":"Hartnell NR, Wilson JP. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration. Pharmacotherapy. 2004;24(6):743\u2013749.","journal-title":"Pharmacotherapy"},{"issue":"9237","key":"1302013_CR14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20131259.","journal-title":"Lancet"},{"issue":"4","key":"1302013_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/fampra\/14.4.279","volume":"14","author":"RM Martin","year":"1997","unstructured":"Martin RM, Hilton SR, Kerry SM. The impact of the October 1995 \u201cpill scare\u201d on oral contraceptive use in the United Kingdom: analysis of a general practice automated database. Fam Pract. 1997;14(4):279\u2013284.","journal-title":"Fam Pract"},{"key":"1302013_CR16","doi-asserted-by":"crossref","first-page":"c7452","DOI":"10.1136\/bmj.c7452","volume":"342","author":"F Godlee","year":"2011","unstructured":"Godlee F, Smith J, Marcovitch H. Wakefield\u2019s article linking MMR vaccine and autism was fraudulent. BMJ. 2011;342:c7452.","journal-title":"BMJ"},{"issue":"4","key":"1302013_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JRS-2002-286","volume":"15","author":"C Medawar","year":"2002","unstructured":"Medawar C, Herxheimer A, Bell A, Jofre S. Paroxetine, Panorama and user reporting of ADRs: consumer intelligence matters in clinical practice and post-marketing drug surveillance. Int J Risk Saf Med. 2002;15(4):161\u2013169.","journal-title":"Int J Risk Saf Med"},{"issue":"8172","key":"1302013_CR18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(80)91306-9","volume":"1","author":"L Lasagna","year":"1980","unstructured":"Lasagna L. The Halcion story: trial by media. Lancet. 1980;1(8172):815\u2013816.","journal-title":"Lancet"},{"key":"1302013_CR19","volume-title":"Ledger\u2019s death puts the focus on sleeping pill","author":"A Cresswell","year":"2016","unstructured":"Cresswell A. Ledger\u2019s death puts the focus on sleeping pill. The Australian Web site Accessed March 27, 2016 http:\/\/www.theaustralian.com.au\/news\/health-science\/ledgers-death-puts-the-focus-on-sleeping-pill\/story-e6frg8y6-1111115402576. Published January 26, 2008."},{"key":"1302013_CR20","volume-title":"Oscars News: Heath Ledger\u2019s Academy Award Will Go to His Daughter Someday","author":"A Swartz","year":"2016","unstructured":"Swartz A. Oscars News: Heath Ledger\u2019s Academy Award Will Go to His Daughter Someday. Mic Web site Accessed April 14, 2016 https:\/\/mic.com\/articles\/136249\/oscars-news-heath-ledger-s-academy-award-will-go-to-his-daughter-someday. Published February 25, 2016."},{"issue":"5","key":"1302013_CR21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.sleep.2009.09.012","volume":"11","author":"AN Roy","year":"2010","unstructured":"Roy AN, Smith M. Prevalence and cost of insomnia in a state Medicaid feefor-service population based on diagnostic codes and prescription utilization. Sleep Med. 2010;11(5):462\u2013469.","journal-title":"Sleep Med"},{"key":"1302013_CR22","unstructured":"United States Food and Drug Administration Web site Questions and Answers on FDA\u2019s Adverse Event Reporting System (FAERS). Accessed December 19, 2016 http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects. Updated May 5, 2016."},{"issue":"7","key":"1302013_CR23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/pds.3805","volume":"24","author":"CK Wong","year":"2015","unstructured":"Wong CK, Ho SS, Saini B, Hibbs DE, Fois RA. Standardisation of the FAERS database: a systematic approach to manually recoding drug name variants. Pharmacoepidemiol Drug Saf. 2015;24(7):731\u2013737.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1302013_CR24","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia MJ. International classification of sleep disorders-third edition highlights and modifications. Chest. 2014;146(5):1387\u20131394.","journal-title":"Chest"},{"key":"1302013_CR25","volume-title":"International Classification of Sleep Disorders","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.","edition":"3rd"},{"key":"1302013_CR26","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.","edition":"5th"},{"issue":"6","key":"1302013_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40264-014-0163-x","volume":"37","author":"M Takada","year":"2014","unstructured":"Takada M, Fujimoto M, Yamazaki K, Takamoto M, Hosomi K. Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database. Drug Saf. 2014;37(6):421\u2013431.","journal-title":"Drug Saf"},{"key":"1302013_CR28","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1186\/1752-1947-3-7560","volume":"3","author":"BM Raidoo","year":"2009","unstructured":"Raidoo BM, Kutscher EC. Visual hallucinations associated with varenicline: a case report. J Med Case Rep. 2009;3:7560.","journal-title":"J Med Case Rep"},{"key":"1302013_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1752-1947-6-65","volume":"6","author":"JA Goldner","year":"2012","unstructured":"Goldner JA. Metoprolol-induced visual hallucinations: a case series. J Med Case Rep. 2012;6:65.","journal-title":"J Med Case Rep"},{"key":"1302013_CR30","first-page":"813786","volume":"2013","author":"S Alkhuja","year":"2013","unstructured":"Alkhuja S, Gazizov N, Alexander ME. Sleeptalking! Sleepwalking! Side effects of montelukast. Case Rep Pulmonol. 2013;2013:813786.","journal-title":"Case Rep Pulmonol"},{"issue":"2","key":"1302013_CR31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1377\/hlthaff.19.2.110","volume":"19","author":"MS Wilkes","year":"2000","unstructured":"Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff. 2000;19(2):110\u2013128.","journal-title":"Health Aff"},{"key":"1302013_CR32","unstructured":"United States Food and Drug Administration Web site Prescription Drug Advertising: Questions and Answers. Accessed December 19, 2016 http:\/\/www.fda.gov\/Drugs\/ResourcesForYou\/Consumers\/PrescriptionDrugAdvertising\/ucm076768.htm. Updated June 19, 2015."},{"issue":"2","key":"1302013_CR33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1509\/jppm.21.2.194.17595","volume":"21","author":"J Lexchin","year":"2002","unstructured":"Lexchin J, Mintzes B. Direct-to-consumer advertising of prescription drugs: the evidence says no. Journal of Public Policy & Marketing. 2002;21(2):194\u2013201.","journal-title":"Journal of Public Policy & Marketing"},{"issue":"2","key":"1302013_CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1370\/afm.693","volume":"5","author":"KC Stange","year":"2007","unstructured":"Stange KC. Time to ban direct-to-consumer prescription drug marketing. Ann Fam Med. 2007;5(2):101\u2013104.","journal-title":"Ann Fam Med"},{"issue":"1","key":"1302013_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00002826-200001000-00011","volume":"23","author":"LC Toner","year":"2000","unstructured":"Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol. 2000;23(1):54\u201358.","journal-title":"Clin Neuropharmacol"},{"key":"1302013_CR36","volume-title":"Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs","author":"United States Food and Drug Administration","year":"2016","unstructured":"United States Food and Drug Administration Web site FDA. Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist). Accessed December 19, 2016 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm334033.htm. Published January 10, 2013. Updated January 16, 2016."},{"issue":"2","key":"1302013_CR37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.smrv.2012.05.004","volume":"17","author":"JC Verster","year":"2013","unstructured":"Verster JC, Roth T. Blood drug concentrations of benzodiazepines correlate poorly with actual driving impairment. Sleep Med Rev. 2013;17(2):153\u2013159.","journal-title":"Sleep Med Rev"},{"issue":"4","key":"1302013_CR38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/smrv.2001.0162","volume":"5","author":"T Roehrs","year":"2001","unstructured":"Roehrs T, Roth T. Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev. 2001;5(4):287\u2013297.","journal-title":"Sleep Med Rev"},{"issue":"4","key":"1302013_CR39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2869.2008.00694.x","volume":"17","author":"MR Pressman","year":"2008","unstructured":"Pressman MR, Mahowald MW, Schenck CH, Bornemann MC. No scientific evidence that alcohol causes sleepwalking. J Sleep Res. 2008;17(4):473\u2013474.","journal-title":"J Sleep Res"},{"key":"1302013_CR40","volume-title":"Sleeping pill Halcion banned by Britain","author":"E Rosenthal","year":"2015","unstructured":"Rosenthal E. Sleeping pill Halcion banned by Britain. The Baltimore Sun Web site Accessed October 19, 2015 http:\/\/articles.baltimoresun.com\/1991-10-03\/news\/1991276026_1_halcion-food-and-drug-drug-administration. Published October 3, 1991."},{"issue":"3","key":"1302013_CR41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1039856214530015","volume":"22","author":"M Huthwaite","year":"2014","unstructured":"Huthwaite M, Cleghorn M, MacDonald J \u201cOut of the frying pan\u201d: the challenges of prescribing for insomnia in psychiatric patients. Australas Psychiatry. 2014;22(3):288\u2013291.","journal-title":"Australas Psychiatry"},{"issue":"23","key":"1302013_CR42","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","volume":"21","author":"L Carton","year":"2015","unstructured":"Carton L, Cottencin O, Lapeyre-Mestre M et al. Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends. Curr Pharm Des. 2015;21(23):3280\u20133297.","journal-title":"Curr Pharm Des"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.6452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.6452\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/jcsm.aasm.org\/ViewAbstract.aspx?pid=30945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.6452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:17:34Z","timestamp":1770365854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.5664\/jcsm.6452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2,15]]}},"alternative-id":["1302013"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.6452","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]},"assertion":[{"value":"1 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}